SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019842
Filing Date
2024-05-15
Accepted
2024-05-15 16:06:48
Documents
76
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1541547
2 ex10-6.htm EX-10.6 272325
3 ex31-1.htm EX-31.1 18911
4 ex31-2.htm EX-31.2 19112
5 ex32-1.htm EX-32.1 9089
  Complete submission text file 0001493152-24-019842.txt   9295335

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ocx-20240331.xsd EX-101.SCH 58934
7 XBRL CALCULATION FILE ocx-20240331_cal.xml EX-101.CAL 74750
8 XBRL DEFINITION FILE ocx-20240331_def.xml EX-101.DEF 349941
9 XBRL LABEL FILE ocx-20240331_lab.xml EX-101.LAB 497482
10 XBRL PRESENTATION FILE ocx-20240331_pre.xml EX-101.PRE 450457
80 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1601361
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 24950497
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)